ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EMILIO CASTANEDA M.D.

Endocrinology, Diabetes Metabolism

25,904

$3.09M

1767
1231 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 50%

$119
Average prescription price

Avg: $132

MAGGIE ROSADOMARTINEZ M.D.

Endocrinology, Diabetes Metabolism

19,227

$591K

700
540 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 50%

$31
Average prescription price

Avg: $132

ANGEL ALEJANDRO M.D.

Endocrinology, Diabetes Metabolism

17,713

$1.14M

2096
1956 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 50%

$64
Average prescription price

Avg: $132

ABDUL GHANI MD

Endocrinology, Diabetes Metabolism

16,390

$926K

591
430 are 65+

13%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 50%

$56
Average prescription price

Avg: $132

CARLOS RIVERA MD

Endocrinology, Diabetes Metabolism

16,074

$1.7M

1180
1060 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 50%

$106
Average prescription price

Avg: $132

KENNETH SHEPHARD MD

Endocrinology, Diabetes Metabolism

11,383

$1.43M

1040
873 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 50%

$126
Average prescription price

Avg: $132

HERNAN BAQUERIZO M.D.

Endocrinology, Diabetes Metabolism

11,376

$1.37M

1002
886 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

58%
prescriptions for brand name drugs

Avg: 50%

$120
Average prescription price

Avg: $132

LUIS GUERRERO MD

Endocrinology, Diabetes Metabolism

11,339

$938K

759
635 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 50%

$83
Average prescription price

Avg: $132

MARCELO BENDIX MD

Endocrinology, Diabetes Metabolism

10,732

$1.04M

1090
973 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 50%

$97
Average prescription price

Avg: $132

SONIA JIMENEZ-VICTORES M.D.

Endocrinology, Diabetes Metabolism

10,285

$1.47M

730
616 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

68%
prescriptions for brand name drugs

Avg: 50%

$143
Average prescription price

Avg: $132

FUAD ASHKAR M.D.

Endocrinology, Diabetes Metabolism

10,135

$904K

783
674 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

59%
prescriptions for brand name drugs

Avg: 50%

$89
Average prescription price

Avg: $132

SOFIA VASQUEZ SOLOMON MD

Endocrinology, Diabetes Metabolism

9,881

$1.26M

793
660 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

64%
prescriptions for brand name drugs

Avg: 50%

$128
Average prescription price

Avg: $132

GOVINDAN NAIR M.D.

Endocrinology, Diabetes Metabolism

9,542

$1.14M

662
432 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 50%

$119
Average prescription price

Avg: $132

SERGIO MATHER MD

Endocrinology, Diabetes Metabolism

8,855

$1.62M

909
732 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 50%

$183
Average prescription price

Avg: $132

MARK BORCHELT MD, FACE

Endocrinology, Diabetes Metabolism

8,639

$1.73M

904
705 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 50%

$200
Average prescription price

Avg: $132

MUDIT JAIN M.D.

Endocrinology, Diabetes Metabolism

8,611

$799K

689
562 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 50%

$93
Average prescription price

Avg: $132

RICHARD WEISS MD

Endocrinology, Diabetes Metabolism

8,393

$1.63M

828
688 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 50%

$194
Average prescription price

Avg: $132

ANA APAZA-CONCHA M.D.

Endocrinology, Diabetes Metabolism

8,286

$490K

732
589 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 50%

$59
Average prescription price

Avg: $132

THOMAS OATES MD

Endocrinology, Diabetes Metabolism

8,279

$1.11M

780
647 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 50%

$135
Average prescription price

Avg: $132

AMIR MANZOOR MD

Endocrinology, Diabetes Metabolism

7,967

$872K

510
317 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 50%

$109
Average prescription price

Avg: $132

MARIA SOLANO M.D.

Endocrinology, Diabetes Metabolism

7,870

$1.03M

460
327 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 50%

$131
Average prescription price

Avg: $132

ANNAPOORNA ARUNACHALAM M.D.

Endocrinology, Diabetes Metabolism

7,672

$836K

766
536 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 50%

$109
Average prescription price

Avg: $132

LOURDES LAGONOWICZ M.D.

Endocrinology, Diabetes Metabolism

7,542

$391K

1138
1061 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 50%

$52
Average prescription price

Avg: $132

RUBEN PIPEK MD

Endocrinology, Diabetes Metabolism

7,445

$1.24M

782
663 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 50%

$167
Average prescription price

Avg: $132

MARTIN COHEN MD

Endocrinology, Diabetes Metabolism

7,246

$819K

507
419 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 50%

$113
Average prescription price

Avg: $132

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank